Sex distribution in irAEs among NSCLC patients was reported with a positive trend among women (139 of 295 men [47.1%] and 156 of 295 women [52.9%] with irAEs vs 254 of 505 men [50.3%] and 251 of 505 women [49.7%] with‐out irAEs) 28 .
← all excerpts
Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and meta-analysis.
1
—
—